The Weekly Roundup: April 22-26
ICYMI, this week we had news about a study of upadacitinib versus dupilumab in atopic dermatitis, the European Union’s approval of bimekizumab for HS, and more.
ICYMI, this week we had news about a study of upadacitinib versus dupilumab in atopic dermatitis, the European Union’s approval of bimekizumab for HS, and more.
We are pleased to invite you to the 2024 Psychiatry Update – a three-day meeting with renowned faculty and informative presentations on bipolar disorder, MDD,…
This cohort study examines patients with drug reaction with eosinophilia and systemic symptoms who also have pustules.
In this interview, Dr Carr delves into the Mohs Surgeons Leading the Future project, discussing its objectives, specific projects, selection criteria, and outcomes. Discover how…
In this month’s Cosmetic Conundrums column, explore what dermatology clinicians need to know about false eyelashes to help prevent infections or contact dermatitis.
The prevalence of gastroesophageal reflux disease (GERD) in the United States continues to increase, and up to half of patients with reflux symptoms do not…
The treatment landscape for inflammatory bowel disease (IBD) is evolving rapidly. Novel pharmacologic agents with different mechanisms of action are advancing the management of both…
Researchers have developed a clinical decision support model using machine learning to assist health care providers in predicting diagnoses of hidradenitis suppurativa.
This interactive and dynamic 60-minute symposium will review the standard of care and recommendations for early and aggressive treatment of chronic kidney disease (CKD) and…
After an extremely successful inaugural event, the 2nd Annual Pigmentary Disorders Exchange Symposium will bring back together world-renowned dermatology experts who will spend two full…
This Viewpoint explains the need for emergency contraception as the last chance to avoid pregnancy for patients taking isotretinoin.